Jeffrey M. Switchenko
Papers
3
Total Citations
36
H-Index
3
About
Jeffrey M. Switchenko is a biostatistician whose research focuses on the intersection of surgical oncology, radiation oncology, and patient outcomes, particularly in head and neck cancers. His major contributions center on evaluating treatment efficacy and safety for oropharyngeal squamous cell carcinoma (OPSCC), with a special emphasis on transoral robotic surgery (TORS). Switchenko’s work has provided critical insights into postoperative recovery, such as characterizing acute swallow function after TORS—a study that has garnered 20 citations—and demonstrating that omitting intentional primary site radiation following TORS yields no local-regional failures, a finding cited 10 times. He has also assessed real-world mortality risks, showing that ninety-day mortality after TORS or radiation at accredited facilities is low, with 6 citations. These studies have helped refine clinical decision-making, balancing oncologic control with quality of life. Switchenko’s research is notable for its methodological rigor, leveraging large databases like the NCDB to produce generalizable evidence. His work is widely referenced by surgeons and radiation oncologists, underscoring its impact on optimizing treatment protocols for HPV-associated OPSCC. For students and researchers, Switchenko exemplifies how biostatistics can bridge surgical innovation and patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3